## **Core Concept**
Toxoplasmosis is a parasitic infection caused by *Toxoplasma gondii*, which can be particularly problematic during pregnancy due to the risk of transmission to the fetus. The management of maternal toxoplasmosis aims to prevent fetal infection and reduce the severity of the disease if transmission occurs.

## **Why the Correct Answer is Right**
The correct answer, **Spiramycin**, is a macrolide antibiotic that is considered the drug of choice for preventing the transmission of *Toxoplasma gondii* from mother to fetus during pregnancy. It works by reducing the parasitic load in the placenta and, consequently, the risk of fetal infection. Spiramycin is preferred in the first and early second trimester due to its safety profile and effectiveness in reducing transmission.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although antiparasitic drugs are relevant, the specifics of this choice are not provided, making it an invalid option.
- **Option B:** This option is incorrect because, while it might represent another antimicrobial or antiparasitic agent, it is not the first choice for maternal toxoplasmosis.
- **Option D:** This option is incorrect because it likely represents another treatment option that is not the preferred first-line treatment for preventing maternal-fetal transmission of toxoplasmosis.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Spiramycin** is used to prevent fetal infection in cases of maternal toxoplasmosis, especially during the first and early second trimesters. In cases of confirmed fetal infection or later in pregnancy, other treatments like **Sulfadiazine** and **Pyrimethamine** (with folinic acid) may be considered, but **Spiramycin** remains the first line for prevention of transmission.

## **Correct Answer:** . **Spiramycin**